Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Chief Financial Officer | July 18, 2023 | July 20, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date July 18, 2023 · Filed July 20, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,775 |
Ending reported balance
After 2023-07-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-07-18 · Exercise / conversion · Acquired 30,147 · Balance 84,179 F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Row 2 · 2023-07-19 · Sale · Disposed 13,404 · Balance 70,775 F2: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 18, 2023 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.92 to $10.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-07-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-07-18 · Exercise / conversion · Acquired 30,147 · Balance 0 F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 18, 2023
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.92 to $10.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F5: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 19, 2023 Filed Jul 20, 2023 16:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 13,404 | $10.20 | $136,720.80 |
DisclosureSEC source: 0001666071-23-000097 · wk-form4_1689883832.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,775 F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 18, 2023 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.92 to $10.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| July 18, 2023 Filed Jul 20, 2023 16:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 30,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000097 · wk-form4_1689883832.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5 · derivative.exercise_date: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F5 · derivative.expiration_date: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| July 18, 2023 Filed Jul 20, 2023 16:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 30,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000097 · wk-form4_1689883832.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 18:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 649 | $5.68 | $3,686.32 |
DisclosureSEC source: 0001666071-23-000078 · wk-form4_1687818703.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,032 F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on June 22, 2023. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 18:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 2,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000078 · wk-form4_1687818703.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,034 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: 25% of the RSUs shall vest on March 22, 2023 with the remainder vesting in twelve equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: 25% of the RSUs shall vest on March 22, 2023 with the remainder vesting in twelve equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 18:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 2,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000078 · wk-form4_1687818703.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| April 05, 2023 Filed May 3, 2023 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 3,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027209 · doc4.xml · derivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,818 Underlying: Common Stock · 3,409 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 05, 2023 Filed May 3, 2023 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 3,409 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-027209 · doc4.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 16:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 9,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000049 · wf-form4_168063897672513.xml · derivative · entry 4 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,677 Underlying: Common Stock · 9,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 16:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 9,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000049 · wf-form4_168063897672513.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| March 22, 2023 Filed Apr 4, 2023 16:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 8,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000049 · wf-form4_168063897672513.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,411 Underlying: Common Stock · 8,136 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| March 22, 2023 Filed Apr 4, 2023 16:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 8,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000049 · wf-form4_168063897672513.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 16:09 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 8,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000002 · wf-form4_167364418422216.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,137 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award. F3 · derivative.expiration_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 16:09 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 8,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000002 · wf-form4_167364418422216.xml · derivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,137 Underlying: Common Stock · 8,137 shares Expires not disclosed F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award. F3 · derivative.expiration_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 16:09 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 8,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000002 · wf-form4_167364418422216.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 17:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000159 · wf-form4_167097064105132.xml · derivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 12 months after the Certification. F2 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 12 months after the Certification. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 17:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000159 · wf-form4_167097064105132.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2022 Filed Nov 8, 2022 16:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 68 | $4.00 | $271.66 |
DisclosureSEC source: 0001666071-22-000142 · wf-form4_166794431813983.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,413 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 16:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,234 | $4.32 | $5,330.88 |
DisclosureSEC source: 0001666071-22-000142 · wf-form4_166794431813983.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,481 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.17 to $4.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 06, 2022 Filed Nov 3, 2022 16:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000138 · wf-form4_166750637805639.xml · derivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "October Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the October Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the October Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 12 months after the October Certification. F3 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "October Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the October Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the October Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 12 months after the October Certification. Read SEC document |
| October 06, 2022 Filed Nov 3, 2022 16:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000138 · wf-form4_166750637805639.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| August 05, 2022 Filed Aug 8, 2022 16:37 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 589 | $14.90 | $8,776.10 |
DisclosureSEC source: 0001666071-22-000109 · wf-form4_165999102243417.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,840 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on June 9, 2022. F2 · balance_after: Includes 291 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 16:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 30,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000091 · wf-form4_165835062741159.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,147 Underlying: Common Stock · 30,147 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5 · derivative.exercise_date: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F5 · derivative.expiration_date: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| June 09, 2022 Filed Jul 20, 2022 16:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000091 · wf-form4_165835062741159.xml · derivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F3 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| June 09, 2022 Filed Jul 20, 2022 16:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000091 · wf-form4_165835062741159.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| May 10, 2022 Filed May 10, 2022 16:38 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $29.20 | $7,300.00 |
DisclosureSEC source: 0001666071-22-000065 · wf-form4_165221507107163.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,263 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2021. Read SEC document |
| May 05, 2022 Filed May 9, 2022 16:08 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 4,634 | $34.64 | $160,521.76 |
DisclosureSEC source: 0001666071-22-000060 · wf-form4_165212687893669.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,513 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $34.37 to $34.94, inclusive. Read SEC document |
| May 05, 2022 Filed May 9, 2022 16:08 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 4,686 | $34.13 | $159,933.18 |
DisclosureSEC source: 0001666071-22-000060 · wf-form4_165212687893669.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,147 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $33.37 to $34.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| April 11, 2022 Filed Apr 11, 2022 16:05 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $46.75 | $11,687.50 |
DisclosureSEC source: 0001666071-22-000046 · wf-form4_164970748986527.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,833 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2021. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 19:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000037 · wf-form4_164937377602615.xml · derivative · entry 4 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F5 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 19:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000037 · wf-form4_164937377602615.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 19:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 3,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000037 · wf-form4_164937377602615.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,227 Underlying: Common Stock · 3,408 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 19:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 3,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000037 · wf-form4_164937377602615.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 9,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000033 · wf-form4_164919204547998.xml · derivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,355 Underlying: Common Stock · 9,678 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 9,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000033 · wf-form4_164919204547998.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| March 24, 2022 Filed Mar 24, 2022 19:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantCommon Stock | 2,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000029 · wf-form4_164816588107192.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,122 F1 · shares: Represents a restricted stock unit ("RSU") award. The shares underlying the RSU award vested immediately upon grant. Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 19:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 32,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000029 · wf-form4_164816588107192.xml · derivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,547 Underlying: Common Stock · 32,547 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: 25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: 25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| March 10, 2022 Filed Mar 10, 2022 16:30 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $52.97 | $13,242.50 |
DisclosureSEC source: 0001666071-22-000024 · wf-form4_164694779046376.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,105 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2021. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $70.00 | $17,500.00 |
DisclosureSEC source: 0001666071-22-000009 · wf-form4_164463407090421.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,355 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2021. Read SEC document |
| January 10, 2022 Filed Jan 11, 2022 16:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $61.02 | $15,255.00 |
DisclosureSEC source: 0001666071-22-000003 · wf-form4_164193636492717.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,605 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 16:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 380 | $69.63 | $26,459.40 |
DisclosureSEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 5 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,855 F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021. F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $69.28 to $70.13, inclusive. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 16:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 820 | $68.66 | $56,301.20 |
DisclosureSEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 4 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,235 F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $68.18 to $69.08, inclusive. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 16:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 539 | $67.62 | $36,447.18 |
DisclosureSEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,055 F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $67.18 to $68.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5) and (6) to this Form 4. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 16:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $71.45 | $17,862.50 |
DisclosureSEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,594 F2 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 16:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · derivative · entry 7 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F7 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F7 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 16:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · derivative · entry 6 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F7 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F7 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 16:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 16:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $88.41 | $22,102.50 |
DisclosureSEC source: 0001666071-21-000228 · wf-form4_163657842402014.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,094 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 17:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 200 | $92.96 | $18,592.00 |
DisclosureSEC source: 0001666071-21-000222 · wf-form4_163641037425146.xml · nonDerivative · entry 4 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,344 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $92.94 to $92.98, inclusive. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 17:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 150 | $92.11 | $13,816.50 |
DisclosureSEC source: 0001666071-21-000222 · wf-form4_163641037425146.xml · nonDerivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,544 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $91.88 to $92.5725, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.